about
The impact of MeCP2 loss- or gain-of-function on synaptic plasticityBDNF deregulation in Rett syndromeVascular dysfunction in a mouse model of Rett syndrome and effects of curcumin treatmentEpigenetics of Renal Development and DiseaseAnimal models of intellectual disability: towards a translational approachDeveloping and applying the adverse outcome pathway concept for understanding and predicting neurotoxicityMerging data from genetic and epigenetic approaches to better understand autistic spectrum disorder.CpG and Non-CpG Methylation in Epigenetic Gene Regulation and Brain FunctionCo-localization of the oncogenic transcription factor MYCN and the DNA methyl binding protein MeCP2 at genomic sites in neuroblastoma.Impact of induced pluripotent stem cells on the study of central nervous system diseasePrenatal maternal immune activation causes epigenetic differences in adolescent mouse brain.Association study in siblings and case-controls of serotonin- and oxytocin-related genes with high functioning autism.Age-dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autismFetal environment, epigenetics, and pediatric renal disease.Neuronal chromatin dynamics of imprinting in development and diseaseComplexities of Rett syndrome and MeCP2Neuroepigenomics: Resources, Obstacles, and Opportunities.Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements.Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders.A genomic point-of-view on environmental factors influencing the human brain methylome15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain.The Role of Epigenetic Change in Autism Spectrum Disorders.Role of MeCP2, DNA methylation, and HDACs in regulating synapse function.Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity.Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities.Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in AutismEnhanced long term potentiation and decreased AMPA receptor desensitization in the acute period following a single kainate induced early life seizureThe behavioral phenotype in MECP2 duplication syndrome: a comparison with idiopathic autism.DNA Methylation Profiling at Single-Base Resolution Reveals Gestational Folic Acid Supplementation Influences the Epigenome of Mouse Offspring Cerebellum.Epigenetic layers and players underlying neurodevelopment.The landscape of DNA methylation amid a perfect storm of autism aetiologies.Does microglial dysfunction play a role in autism and Rett syndrome?Training communication abilities in Rett Syndrome through reading and writing.The environmental neurotoxicant PCB 95 promotes synaptogenesis via ryanodine receptor-dependent miR132 upregulation.Knowledge-Guided Bioinformatics Model for Identifying Autism Spectrum Disorder Diagnostic MicroRNA Biomarkers.Epigenomic strategies at the interface of genetic and environmental risk factors for autismThe contribution of oxytocin and vasopressin to mammalian social behavior: potential role in autism spectrum disorder.Translational research: Rett syndrome and tuberous sclerosis complex.Genetic variation in the epigenetic machinery and mental health.The contribution of epigenetics to understanding genetic factors in autism.
P2860
Q26852720-6EA3F4A3-7DEE-4262-848A-DEFC05886A7CQ27005901-B38FC4F5-DDC0-4817-9AFD-0D05D352088DQ27318090-8CBCB17C-9FAA-4AD3-B792-9ABEE281260FQ28079434-A7170284-F1F7-462D-82CF-BEFF77AB540EQ28389500-FBB4F2EC-2D1A-49B8-BF0B-3DA6923149C0Q28394433-E3C85651-9979-4240-846E-64C5AD8A8B89Q31020010-B36C8DE6-33E6-40C7-8DBA-FB57030AC10FQ33836737-DCB371E7-C877-4B87-8443-ED4FC4A147D6Q33952442-3E61D70B-F674-47F1-B8B0-97FC3AD0B727Q34161356-DC47ECDC-F8C4-4304-A348-FAF30BBAF279Q34370478-3362BF7A-2AC8-4A60-90DA-F9225B074C89Q34470381-0198FE5A-16AB-4159-9DF7-CE994ACEAF37Q34599738-D415291D-2E08-4693-849D-F97E7A91467EQ34625920-1535B2DE-DD46-4D45-A1A3-AEA5F5E8B0FAQ34956275-CD2A57E3-C9B4-4F72-9172-28323F1A338FQ35080184-C01FC95E-6D60-45BF-BF8A-AE7424CEF063Q35110560-B6DB2560-4CC5-48C7-BD30-88C185C6474AQ35110620-3E5CF4E3-87DC-48C9-B9DE-83CCDD6D84F4Q35155976-A04CFEEB-6A8A-4A11-B5F7-DA56014E91B6Q35159036-BF132846-875D-45ED-8864-00E6A3804BE5Q35389369-CD8A83EE-E77A-4C8B-B445-12E4EA1789CDQ35646482-49E201FE-F04B-4080-ADBD-DB1E09DC9337Q35680712-E478A4C2-E439-4CC4-895E-709C9C7248A7Q35745244-27ED9042-5800-4336-AC2C-763FB574EC01Q35765423-2D1AEBE3-391B-4E11-9BA8-03214DDDBE8BQ36168459-96959F27-A05B-4294-A276-108900C4D780Q36546885-6F19B939-36D0-491D-894C-1922AF8DC47EQ36628431-F300796A-07D9-48D4-88DD-E8AF0D47BF3BQ36861331-5CBD82FF-6DE9-4327-A88A-4F3F46A742BBQ37076219-D44CE580-D2B8-4911-BA7D-281A57EA7F68Q37137826-3D8A0C2D-04A1-4C59-8639-1AE0AD0E4365Q37157706-86328FBF-F831-4F19-89A7-B6D5FA251F8BQ37371802-F4B4CF1D-B5FF-4B75-A9EB-E6A8695DCE90Q37479446-2B606823-0B5A-47BF-B571-B6E35AEB153EQ37522492-A78D6BEE-8341-4779-B6D7-E0A9F6FCBDC8Q37638802-EDA19776-CC7D-49DD-8B5A-B8F96CCDC055Q37819758-A80ECE6B-8E75-43AB-9643-3EA91F7256E4Q37942280-76CD630E-E82B-4175-B466-9004AE0884DEQ37981593-E0CB8362-1955-4253-8853-957F6BFEF759Q38152705-64A7B2E4-7F15-4BF0-9827-1F0D9EA007DB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evolving role of MeCP2 in Rett syndrome and autism.
@en
Evolving role of MeCP2 in Rett syndrome and autism.
@nl
type
label
Evolving role of MeCP2 in Rett syndrome and autism.
@en
Evolving role of MeCP2 in Rett syndrome and autism.
@nl
prefLabel
Evolving role of MeCP2 in Rett syndrome and autism.
@en
Evolving role of MeCP2 in Rett syndrome and autism.
@nl
P2860
P356
P1433
P1476
Evolving role of MeCP2 in Rett syndrome and autism.
@en
P2093
Dag H Yasui
Janine M LaSalle
P2860
P304
P356
10.2217/EPI.09.13
P577
2009-10-01T00:00:00Z